Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Genome Sciences Closes Second Round of Financing

NEW YORK, April 4 (GenomeWeb News) - Oxford Genome Sciences has closed a second round of venture capital investment, the company said today. The size of the investment was not disclosed.


Oxfordsaid the financing has allowed it to move into a larger custom-built proteomics facility near Oxford, UK. The funding will also be used to accelerate the company's growth, primarily through partnerships.


According to Oxford, the South East Growth Fund, an existing investor, led the round. Oxford Capital Partners participated as a new investor.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.